Home›People›Jakob Dupont, M.D., M.A.
JA

Jakob Dupont, M.D., M.A.

Director at Avenzo Therapeutics.

Director
Updated Oct 27, 2026·Latest SEC filing Sep 5, 2025·Suggest an edit

About Jakob Dupont, M.D., M.A.

Jakob Dupont, M.D., M.A. is a director at Avenzo Therapeutics.

Jakob Dupont, M.D., M.A. first appears on SEC filings in 2024.

Experience

This experience comes from SEC filings. The years are when the filings name Jakob Dupont, M.D., M.A. in the role, so the role may have started earlier or lasted longer.

Avenzo Therapeutics, Inc.
Director
2024 – 2025 · San Diego, CA

Key Colleagues at Startups

The people Jakob Dupont, M.D., M.A. works with at each company, as listed on that company's latest Form D.

Avenzo Therapeutics, Inc. · Form D, Sep 5, 2025
CG
Carl Gordon
Director
GN
PM
JL
Judith Li
Director
PT
Paolo Tombesi
Executive officer
MH
Mohammad Hirmand
Executive officer
SG
SL
Scott Lipman
Executive officer
AC
Athena Countouriotis
Executive officer and director
BS
Brian Sun
Executive officer

Sources

  1. SECAvenzo Therapeutics, Inc. Form D, filed Sep 5, 2025